Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001415889-25-015010
Filing Date
2025-05-30
Accepted
2025-05-30 16:35:38
Documents
4

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 15865
2 POWER OF ATTORNEY FOR NIMISH SHAH ex-24-05302025_080522.htm EX-24.1 5256
3 POWER OF ATTORNEY FOR BONG KOH ex-24-05302025_080523.htm EX-24.2 5247
4 JOINT FILING AGREEMENT ex-99-05302025_080524.htm EX-99.1 6872
  Complete submission text file 0001415889-25-015010.txt   34964
Mailing Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036
Business Address 530 FIFTH AVENUE, 22ND FLOOR NEW YORK NY 10036 212-444-4100
Venrock Healthcare Capital Partners III, L.P. (Filed by) CIK: 0001738048 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 388-5600
Oric Pharmaceuticals, Inc. (Subject) CIK: 0001796280 (see all company filings)

EIN.: 471787157 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91490 | Film No.: 251011601
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)